Associations between inflammatory endotypes and phenotypes of obesity at young patients with bronchial asthma Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities Year: 2020
The burden of obesity for asthmatic patients. Source: International Congress 2019 – Comorbidities in COPD and asthma: body composition and diabetes Year: 2019
COPD patients with asthma, characteristics and risk of exacerbations Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019
The prevalence of allergic rhinitis among adult patients with diagnoses of asthma in childhood Source: Eur Respir J 2002; 20: Suppl. 38, 119s Year: 2002
Prediction of the risk of future exacerbations in patients with severe persistent allergic asthma Source: Annual Congress 2005 - Severe asthma: perception and management Year: 2005
Effect of omalizumab on the risk of hospitalisation in patients with uncontrolled severe asthma in real-life. The PAX-LASER cohort Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010
Multi-symptom asthma as an indication of disease severity in epidemiology Source: Eur Respir J 2011; 38: 825-832 Year: 2011
Under-diagnosis and under-evaluation of the severity of COPD in at-risk subjects Source: Eur Respir J 2004; 24: Suppl. 48, 287s Year: 2004
The evaluation of systemic inflammation in COPD patients comorbided with cardiovascular diseases or diabetes mellitus Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011
Prevalence of undiagnosed COPD in patients with established cardiovascular diseases Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD Year: 2010
Dupilumab efficacy in children with uncontrolled, moderate-to-severe asthma with and without an allergic phenotype Source: Virtual Congress 2021 – Advances in childhood asthma: biologics, biomarkers and infections Year: 2021
Dupilumab efficacy in patients with GINA-defined type 2 asthma: TRAVERSE Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD Year: 2021
The effect of obesity or overweight on airway hyperresponsiveness and clinical features in patients with asthma Source: Annual Congress 2011 - Asthma: risk factors and comorbidities Year: 2011
Risk factors for severe exacerbations in a real-life population of adults with severe refractory asthma Source: International Congress 2017 – Many faces of asthma and allergies Year: 2017
The prevalence of asthma and allergic diseases in working children Source: Eur Respir J 2007; 30: Suppl. 51, 400s Year: 2007
Uncontrolled asthma has a higher disease burden compared to controlled asthma in adult onset but not in childhood onset asthma Source: Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden Year: 2020
Specific comorbidities and low adherence are independent risk factors for poorer asthma control and exacerbations in patients with difficult-to-control asthma Source: International Congress 2019 – Long-term evaluation and control of airway diseases Year: 2019
The prevalence of chronic obstructive pulmonary disease (COPD) in individuals with diabetes, hypertension, asthma, or mood/anxiety disorders: A Canadian population study Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities Year: 2012
Comorbidities in asthma: the role of obesity in children with asthma Source: Virtual Congress 2020 – Which paediatric asthma guidelines are the most appropriate for children and adolescents? Year: 2020
Virus-induced exacerbation in patients with different forms of non-allergic late-onset asthma Source: Eur Respir J 2003; 22: Suppl. 45, 516s Year: 2003